本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Agios Pharmaceuticals, Inc.

32.81
-0.4100-1.23%
成交量:135.40萬
成交額:4,448.40萬
市值:19.51億
市盈率:-4.68
高:33.48
開:33.23
低:32.22
收:33.22
52周最高:46.00
52周最低:22.24
股本:5,947.16萬
流通股本:5,008.85萬
量比:1.65
換手率:2.70%
股息:- -
股息率:- -
每股收益(TTM):-7.0075
每股收益(LYR):-7.1203
淨資產收益率:-34.34%
總資產收益率:-22.24%
市淨率:1.90
市盈率(LYR):-4.61

資料載入中...

2025/04/08

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/03/05

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2025/03/04

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/03/03

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/03/03

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/03/03

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/03/03

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/02/13

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2025/02/13

重要事件披露

Form 8-K - Current report
2025/02/13

重要事件披露

Form 8-K - Current report
2025/01/13

重要事件披露

Form 8-K - Current report
2025/01/06

重要事件披露

Form 8-K - Current report
2025/01/03

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/11/14

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/08

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/11/08

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/08

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/11/07

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/10/31

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/10/31

重要事件披露

Form 8-K - Current report